Last reviewed · How we verify
NCT03890328
RF-assisted Splenic Preservation VS Conventional Treatment of Blunt Splenic Injury.
NA trial testing radiofrequency ablation in Radiofrequency Can be Used to Treat Splenic Trauma Because of Its Excellent Coagulation Hemostasis in 122 participants. Completed in 1 June 2014.
1 June 2014
Quick facts
| Lead sponsor | Southwest Hospital, China |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 122 |
| Start date | 1 March 2009 |
| Primary completion | 1 June 2014 |
| Estimated completion | 1 June 2014 |
| Sites | 1 location across China |
Drugs / interventions tested
- radiofrequency ablation
Conditions studied
- Radiofrequency Can be Used to Treat Splenic Trauma Because of Its Excellent Coagulation Hemostasis — all drugs for Radiofrequency Can be Used to Treat Splenic Trauma Because of Its Excellent Coagulation Hemostasis →
Sponsor
Southwest Hospital, China
Who can join
Under 70, any sex, with Radiofrequency Can be Used to Treat Splenic Trauma Because of Its Excellent Coagulation Hemostasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Radiofrequency (RF) can be used to treat splenic trauma because of its excellent coagulation hemostasis. This study aimed to compare the efficacy of RF-assisted spleen-preserving surgery with that of conventional splenorrhaphy/splenectomy in the treatment of blunt splenic injury. A total of 122 patients with splenic trauma admitted to two tertiary referral centers from June 2011 to June 2014 were included in this prospective cohort study. The 67 patients at one center were treated by radiofrequency-assisted spleen-preserving therapy (RF group), and the 55 patients admitted at the other center underwent conventional treatment (CT group). Demographics and clinical characteristics of the two groups were comparable. Compared to traditional splenorrhaphy and splenectomy, RF-assisted splenic hemostasis and salvage was safe, effective and easy to use in the treatment of splenic injuries. In particular for high-grade splenic injuries, these techniques preserved sufficient splenic tissue without any increase in patients with surgical risk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03890328
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of radiofrequency ablation
Trials testing the same drug.
- NCT07095803 — Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy · Phase 2 · not yet recruiting
- NCT06984731 — The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion. · recruiting
- NCT06798038 — Comparison of the Efficacy of Chemical Genicular Nerve Neurolysis Using Alcohol or Phenol Versus Radiofrequency Ablation · Phase 1 · not yet recruiting
- NCT05738941 — Interventional Radiology in Bony Lesions · unknown
- NCT06856265 — Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardi · NA · not yet recruiting
Other Southwest Hospital, China trials
Trials by the same sponsor.
- NCT07469293 — Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke · Phase 3 · not yet recruiting
- NCT07294209 — Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients · Phase 4 · recruiting
- NCT07251374 — Osteomyelitis Multi-center Prospective Cohort Study · not yet recruiting
- NCT06894433 — Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage · NA · recruiting
- NCT06791538 — Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03890328 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Southwest Hospital, China
- Last refreshed: 26 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03890328.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing